Prediction Study of the Pain Phase of Migraine Attacks in Patients With Episodic Migraine

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The study of the ability to predict pain in a migraine attack, through premonitory symptoms and through an ambulatory monitoring device through real-time recording of hemodynamic variables, is one of the strategic lines of research of the unit. of Headaches at the Hospital de La Princesa since 2013 together with the Complutense and Polytechnic University of Madrid. Their results have been reflected in various publications (Pagán J, et al. Sensors 2015; Gago-Veiga AB, et al. J Pain Res 2018) and have promoted the creation of several invention patents.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Age between 15 years and 69 years.

• Diagnosed with migraine by a headache neurologist and according to the criteria proposed by ICHD-3.

• History of migraine of at least 1 year of evolution.

• Normal neurological examination.

• Have given your informed consent.

• Be able to describe your clinical situation and the characteristics of your headache.

• Have an average of 10 to 14 migraine days per month in the three months prior to inclusion (high-frequency episodic migraine).

• User-level management capacity of smartphone type electronic devices.

• Be able to complete two months of study follow-up.

Locations
Other Locations
Spain
Hospital Universitario de La Princesa
RECRUITING
Madrid
Contact Information
Primary
Ana Beatriz Gago Veiga
anabeatriz.gago@salud.madrid.org
+34 915202416
Backup
Iris Fernández Lázaro
irisfdezlaz@gmail.com
Time Frame
Start Date: 2023-10-09
Estimated Completion Date: 2025-12
Participants
Target number of participants: 70
Treatments
Patients with episodic migraine
Patients with episodic migraine who present between 4 and 10 migraine attacks per month. These patients must have a diagnosis of migraine by a headache neurologist and according to the criteria proposed by ICHD-3. In addition, they must present at least 1 year of evolution of the migraine, as well as a normal neurological examination and have given their informed consent.
Control patients
People who have never had a headache episode with migraine characteristics. These may present, at most, one episode per month of headache with non-migraine characteristics in the last 3 months. In turn, they should not have a family history of migraine (1st and 2nd degree).
Sponsors
Collaborators: Hospital Universitario La Fe, Hospital Vall d'Hebron, Hospital Donostia, Hospital Universitario Marqués de Valdecilla, Hospital Clínico Universitario Lozano Blesa, Hospital Clínico Universitario de Valladolid
Leads: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

This content was sourced from clinicaltrials.gov